Dia-blogging

Friday was huge. The Food and Drug Administration approved the Pfizer product--to be marketed as Exubera--that looks to transform insulin therapies forever:

The first inhalable version of insulin won federal approval Friday, giving millions of adult diabetics an alternative to some of the injections they now endure.

The Food and Drug Administration said the Pfizer Inc. insulin, to be marketed as "Exubera," is the first new way of delivering insulin since the discovery of the hormone in the 1920s.

As a diabetic who has shown a great aversion to pumps, this development does my heart good.